|
Status |
Public on Sep 01, 2011 |
Title |
231_GATA3_rep3 |
Sample type |
RNA |
|
|
Source name |
breast cancer cell line transduced with GATA3
|
Organism |
Homo sapiens |
Characteristics |
cell line: breast cancer cell line MDA-MB-231 ectopic expression: GATA3 and GFP rep: 3
|
Treatment protocol |
MDA-MB-231 were transduced with a lentivirus expressing eGFP alone or GATA3 and eGFP and cells were sorted for GFP expression
|
Growth protocol |
MDA-MB-231 expressing control GFP or GATA3 were grown in DMEM/high glucose supplemented with 10% FBS, sodium pyruvate and pen/strep. 1.5 million cells were seeded into 100 mm dishes and RNA collected after 2 days.
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was isolated by Trizol® according to the manufacturer's instructions. All samples used for microarray analysis had a high quality score (RIN >9).
|
Label |
biotin
|
Label protocol |
RNA (1 ug) was reverse transcribed with a T7-oligo(dT) primer and biotin labeled using the Affymetrix One Cycle Target Labeling kit (Affymetrix) following the manufacturer’s protocol.
|
|
|
Hybridization protocol |
Hybridized to Affymetrix human U133 plus 2.0 GeneChips
|
Scan protocol |
Scanned on an Affymetrix GeneChip scanner 3000 and data collected using Affymetrix GCOS software
|
Description |
Raw data file: Chu_GATA_3_122308.CEL
|
Data processing |
Data was processed into log base 2 gene expression measures with gcRMA algorithm and quantile normalization. The data were processed in BRB-ArrayTools developed by Richard Simon and BRB-ArrayTools Development Team (http://linus.nci.nih.gov/BRB-ArrayTools.html).
|
|
|
Submission date |
Sep 21, 2010 |
Last update date |
Sep 01, 2011 |
Contact name |
Jeffrey E Green |
E-mail(s) |
[email protected]
|
Phone |
3014355193
|
Fax |
3014968709
|
Organization name |
NCI
|
Street address |
Rm 4054, 37 Convent Drive
|
City |
Bethesda |
State/province |
MD |
ZIP/Postal code |
20892 |
Country |
USA |
|
|
Platform ID |
GPL570 |
Series (1) |
GSE24249 |
GATA3 Reprograms Basal Breast Cancer Cells towards a Luminal Subtype and Inhibits Metastases through Suppression of Lysyl Oxidase |
|